Back to search

Article

Membrane-Activating Triphenylphosphonium Functionalized Ciprofloxacin for Multidrug Resistant Bacteria

2020-10-06

Abstract excerpt

Multidrug resistant (MDR) bacteria have become a severe problem for public health. Developing new antibiotics for MDR bacteria is difficult, from inception to the clinically approved stage. Here, we have used a new approach; we have modified the antibiotic, ciprofloxacin (CFX), with triphenylphosphonium (TPP, PPh3) moiety via ester- (CFX-ester-PPh3) and amide-coupling (CFX-ester-PPh3), to target bacterial membrane...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46fe8a09-1b78-5a8f-b2a5-69f5fe0195b4
DOI
10.20944/preprints202010.0116.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Membrane-Activating Triphenylphosphonium Functionalized Ciprofloxacin for Multidrug Resistant BacteriaDOI 10.20944/preprints202010.0116.v1
Select a neighboring publication to make it the new centre.